throbber
Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 1 of 9 PageID #: 9523
`
`ARTICLE
`
`Air Sparging for Prevention of Antibody
`Disulfide Bond Reduction in Harvested
`CHO Cell Culture Fluid
`
`Melissa Mun,1 Stefanie Khoo,2 Aline Do Minh,1 James Dvornicky,2
`Melody Trexler-Schmidt,2 Yung-Hsiang Kao,3 Michael W. Laird1
`1Late Stage Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California
`94080; telephone: 650 467 4596; e-mail: mlaird@gene.com
`2Purification Development, Genentech, Inc., San Francisco, California
`3Protein Analytical Chemistry, Genentech, Inc., San Francisco, California
`
`ABSTRACT: During the scale-up of several Chinese Hamster Ovary
`(CHO) cell monoclonal antibody production processes, significant
`reduction of the antibody interchain disulfide bonds was observed.
`The reduction was correlated with excessive mechanical cell shear
`during the harvest operations. These antibody reduction events
`resulted in failed product specifications and the subsequent loss of
`the drug substance batches. Several methods were recently developed
`to prevent antibody reduction, including modifying the cell culture
`media, using pre- and post-harvest chemical additions to the cell
`culture fluid (CCF),
`lowering the pH, and air sparging of the
`harvested CCF (HCCF). The work described in this paper further
`explores the option of HCCF air sparging for preventing antibody
`reduction. Here, a small-scale model was developed using a 3-L
`bioreactor to mimic the conditions of a manufacturing-scale harvest
`vessel and was subsequently employed to evaluate several air
`sparging strategies. In addition, these studies enabled further
`understanding of the relationships between cell lysis levels, oxygen
`consumption, and antibody reduction. Finally, the effectiveness of air
`sparging for several CHO cell lines and the potential impact on
`product quality were assessed to demonstrate that air sparging is an
`effective method in preventing antibody reduction.
`Biotechnol. Bioeng. 2015;112: 734–742.
`ß 2014 Wiley Periodicals, Inc.
`KEYWORDS: antibody; disulfide;
`dissolved oxygen; air
`
`lysis;
`
`sparging;
`
`reduction;
`
`stainless steel bioreactors (Andersen and Krummen, 2002; Wurm,
`2004) and the product is separated from the cells via centrifugation
`(Kempken et al., 1995; Roush and Lu, 2008). The product then
`undergoes further downstream purification (Fahrner et al., 2001;
`Kelley, 2007) prior to the bulk formulation steps. During the
`centrifugation process, cells are subjected to mechanical shear
`(Hutchinson et al., 2006) which can lead to the disruption of cell
`membrane integrity. Reduction of antibody interchain disulfide
`bonds has been observed in the scale-up of CHO rMAb production
`processes at Genentech as a result of excessive cell shear during the
`centrifugation process (Trexler-Schmidt et al., 2010). The reduction
`events were caused by intracellular components,
`identified as
`thioredoxin (Trx/TrxR) or thioredoxin-like enzymes, their asso-
`ciated enzyme pathway intermediates (e.g., glucose-6-phosphate
`dehydrogenase, hexokinase), and an energy source (e.g., NADPH)
`(Kao et al., 2010; Koterba et al., 2011), which were released upon cell
`lysis. Studies have shown that disulfide bond reduction is correlated
`to levels of mechanical cell lysis of viable, actively growing cells
`(Hutterer et al., 2013; Trexler-Schmidt et al., 2010) which results in
`the release of active thioredoxin system components. In contrast,
`reduction enzymes released upon cell death may not be active at the
`time of harvest and the energy source may be depleted. Multiple
`strategies have been developed to prevent this antibody reduction
`event including the addition of chemical inhibitors to the CCF and
`HCCF, as well as maintaining a minimum dissolved oxygen (dO2)
`level
`in the HCCF via air sparging to promote an oxidizing
`environment for the antibody (Trexler-Schmidt et al., 2010).
`Mammalian cells rely on several systems to maintain the
`oxidation reduction potential of each intracellular compartment at
`the appropriate state. Some of the sulfhydryl-containing oxido-
`reductase systems commonly studied include thioredoxin/thiore-
`doxin reductase (Trx/TrxR) and glutathione/glutathione disulfide
`(GSH/GSSG). These systems regulate cellular events such as cell
`signaling (Filomeni et al., 2002), formation of disulfide bonds
`(Cumming et al., 2004; Jessop and Bulleid, 2004) and gene
`transcription (Sen and Packer, 1996), and also serve to protect the
`cells from reactive oxygen species (ROS) (Linke and Jakob, 2003;
`Nordberg and Arner, 2001; Shen et al., 2005). Oxygen plays a role as
`
`Introduction
`
`(rMAb) are commonly
`Recombinant monoclonal antibodies
`produced in CHO cells in the biotherapeutics industry. In large-
`scale manufacturing of rMAb, cells are generally cultured in
`
`The present address of Aline Do Minh is Genipro (STNH), Inc.
`Correspondence to: M. W. Laird
`Received 24 June 2014; Revision received 24 September 2014; Accepted 3 November
`2014
`Accepted manuscript online 11 November 2014;
`Article first published online 23 December 2014 in Wiley Online Library
`(http://onlinelibrary.wiley.com/doi/10.1002/bit.25495/abstract).
`DOI 10.1002/bit.25495
`
`734 Biotechnology and Bioengineering, Vol. 112, No. 4, April, 2015
`
`ß 2014 Wiley Periodicals, Inc.
`
`

`

`Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 2 of 9 PageID #: 9524
`
`the terminal electron acceptor in these oxidoreductase systems
`(Shimizu and Hendershot, 2009) and oxygen supplementation has
`previously been applied in protein refolding to promote the correct
`formation of disulfide bonds (Fischer et al., 1993; Menzella et al.,
`2002). With this understanding in mind and coupled with the
`knowledge gained from the studies described by Trexler-Schmidt
`et al. (2010), the dO2 trends of HCCF derived from manufacturing-
`scale harvests were evaluated. Surprisingly, the dO2 level dropped to
`0% within a few hours. This appears to be linked to mechanical cell
`lysis and plays an important role in the subsequent disulfide bond
`reduction event. Therefore, implementation of air sparging in the
`HCCF vessel to promote an oxidizing environment should aid in
`preventing reduction of disulfide bonds.
`Dissolved oxygen control strategies are widely applied in cell
`culture bioreactors. A common sparging strategy employs a dO2
`probe which provides feedback to a PID control loop to scale the air
`and/or oxygen sparge output to a rate appropriate to maintain the
`desired dO2 set-point. Many factors are considered in bioreactor
`design in order to provide adequate gas transfer to maintain high
`cell densities while minimizing potential harmful shear effects from
`agitation or bubble rupture that could damage the cells or protein
`(Al-Rubeai et al., 1995; Chisti, 2001; Merchuk, 1991; Trinh et al.,
`1994).
`This paper explores the method of air sparging as an antibody
`reduction mitigation strategy through the development and
`utilization of a small-scale model to evaluate process requirements
`and characteristics. First, a small-scale model was established using
`a 3-L bioreactor to mimic the conditions of an HCCF tank. This
`small-scale model was then used to evaluate several air sparging
`strategies for effectiveness at preventing disulfide bond reduction
`and potential impact on product quality. Several CHO cell lines were
`tested with this method to ensure robustness for manufacturing and
`to determine if this could be universally applied to prevent antibody
`reduction. These studies also permitted further understanding of
`the relationships between cell lysis levels, oxygen consumption, and
`antibody reduction.
`
`Materials and Methods
`
`Generation of CCF and Production of rMAb in Bioreactors
`
`CHO cells were cultured in 3-L glass stirred tank bioreactors
`(Applikon) in conditions similar to those previously described by
`Chaderjian et al. (2005). Culture conditions (e.g., temperature,
`pH, dO2, and agitation) were controlled and monitored on-line. Off-
`line measurements of pH, dissolved gases (pO2, pCO2), sodium, and
`metabolite concentrations
`(glucose,
`lactate, ammonia) were
`obtained with a NOVA Bioprofile Analyzer. Daily samples were
`taken to monitor cell growth, viability, and titer.
`
`Small-Scale Lysis Model to Generate HCCF With
`Reduction Activity
`
`CCF at the end of the production culture was homogenized using a
`Microfluidics HC-8000 homogenizer, centrifuged, and filtered as
`described previously by Trexler-Schmidt et al. (2010). The non-
`mechanically lysed material (also referred to as “non-lysed”) has
`
`cell lysis levels present from the end of the production culture.
`“Non-lysed” cell lysis levels were consistently between 10–30% for
`the feedstocks used for these studies. The lysis levels reported in
`the data figures throughout this work reflect total
`lysis levels
`(“non-lysed”þ mechanical lysis).
`
`HCCF Pool Incubation in Small-Scale Vessels for
`Sparging Studies
`
`HCCF pools were incubated at a 2-L working volume in sterile 3-L
`glass stirred tank bioreactors (Applikon) with downflow pitched
`blade impellers for up to two days. Conditions were monitored with
`dO2 (Mettler Toledo), pH (Broadley James), and temperature
`probes. Digital control units (B. Braun) were used to control
`agitation rate and maintain dO2 at or above the specified set-points
`by delivering air through an open pipe sparger as required. Air
`sparge rates ranged from 0–50 standard cubic centimeters per
`minute (sccm), which corresponds to 0–0.025 vvm. No N2 sparge
`was used to decrease the dO2 level if it exceeded set-point. The pH
`levels were maintained at specified set-points if called for by the
`experiment design by addition of CO2 or 1 M Na2CO3. HCCF was
`held at ambient temperature without temperature control (18–
`22C). The agitation rate was controlled at 50–100 rpm. Unless
`otherwise noted, a 50 sccm N2 overlay was supplied for all cases
`with dO2 control, while no N2 overlay was employed for non-
`sparged holds. After 1 and 2 day holds, HCCF was purified over a
`lab-scale Protein A affinity column and the pools were frozen at <
`70C until analysis.
`
`HCCF Pool Incubation in Mini-Tanks and Protein A
`Processing
`
`HCCF was held in 50 mL 316-L stainless steel mini-tank containers
`(Flow Components, Dublin, CA) as described previously by Trexler-
`Schmidt et al. (2010). After 1 and 2 day holds, the HCCF was
`purified over a lab-scale Protein A affinity column as described by
`Trexler-Schmidt et al. (2010).
`
`Disulfide Bond Reduction Assay
`
`Microchip capillary electrophoresis (CE) (Agilent 2100 Bioanalyzer)
`was used to quantitate the level of non-reduced antibody as
`described previously by Trexler-Schmidt et al. (2010). The non-
`reduced, intact antibody migrates at 150 kDa.
`
`Mass Transfer Measurements
`
`Volumetric gas transfer coefficients (kLa) were determined for the
`sparge vessel conditions using a dynamic method. Sparge vessels
`were filled with 2-L of cell-free culture media and set to the desired
`agitation and sparge rates at ambient temperature (18–22C). N2 or
`air was added to the bioreactor through the sparger and/or
`headspace to drive the dO2 to ~50 or ~100%, respectively. dO2
`readings were measured with a probe and recorded using
`FermWorks software (Jova Solutions). Based on the equation
`ln (C*CL)¼ kLa tþ constant, data were plotted in a semi-log
`fashion with (C*CL) versus time. Linear regressions were
`
`Mun et al.: Air Sparging for Prevention of Antibody Reduction
`
`735
`
`Biotechnology and Bioengineering
`
`

`

`Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 3 of 9 PageID #: 9525
`
`performed with the slope representing the kLa value for each
`condition.
`
`Cell Lysis Measurements (LDH Assay)
`
`Percent cell lysis was determined by measuring the level of lactate
`dehydrogenase (LDH) as described previously by Trexler-Schmidt
`et al. (2010).
`
`Monoclonal Antibody Protein Concentration Assays
`
`For HCCF samples, an HPLC-based Protein A method was used to
`determine rMAb concentration in order to calculate purification
`load density and yield. The rMAb concentration in the purified
`Protein A pool was measured using UV spectrometry at 280 nm and
`the extinction coefficient for that particular rMAb.
`
`IEC-HPLC Assay
`
`Ion-exchange chromatography (IEC) was used to assess charge
`heterogeneity. Samples were treated with carboxypeptidase B to
`remove C-terminal
`lysine before analysis by cation-exchange
`chromatography using
`a Dionex ProPac WCX-10 column
`(4  250 mm). The mobile phase used in the separation consisted
`of a potassium phosphate/potassium chloride pH 6.9 buffer.
`
`Perturbation Oxygen Uptake Rate (OUR) Measurements
`
`HCCF pools were incubated in 3-L glass stirred tank bioreactors
`with dO2 controlled at 30%. At specified intervals throughout the
`hold period (e.g., every 2–4 h), dO2 control and air sparging were
`turned off and the rate of change in dO2 was calculated over a 5%
`drop. Agitation remained at set-point throughout the hold period
`and during the perturbation.
`
`Results
`
`Establishment of a Small-Scale Sparge Model
`
`An initial experiment was performed to investigate hold conditions
`for the small-scale sparge model. Lysed HCCF (85% lysis) was held
`at a 2-L working volume in 3-L bioreactors at two conditions:
`50 rpm agitation with 50 sccm N2 overlay and 100 rpm agitation
`with no N2 overlay. The rMAb reduction levels in these two hold
`conditions were measured using the Agilent Bioanalyzer assay and
`compared to the control mini-tank hold. As shown in Figure 1,
`rMAb reduction was observed in the mini-tank control after a two-
`day hold time. In contrast, no rMAb reduction occurred with the
`100 rpm agitation and no N2 overlay conditions and reduction was
`accelerated with the 50 rpm agitation and N2 overlay conditions,
`with reduction occurring after a one-day hold time. In addition, a
`significant difference in dO2 levels was observed between the two
`sparge vessel hold conditions due to surface transfer from the
`headspace. The presence of a N2 overlay led to removal of O2 from
`the liquid and helped drive the dO2 levels to 0%. While 0% dO2 was
`maintained for the entire hold period, re-formation of the antibody
`disulfide bonds was observed once the reduction activity (i.e.,
`
`736
`
`Biotechnology and Bioengineering, Vol. 112, No. 4, April, 2015
`
`Figure 1.
`Lysed HCCF (85% total lysis; 65% mechanical lysis) was held in small-
`scale sparge vessels at room temperature (18–22C) at two different hold conditions.
`Levels of rMAb reduction and dO2 were compared between conditions as well as to the
`control mini-tank hold.
`
`intracellular components) was depleted after the two-day hold
`period. Re-formation of the disulfide bonds could be the result of
`the antibody attaining a more stable conformation of the lowest
`energy for its given environment. However, other as yet to be
`defined mechanisms may also be at work here. In the case without a
`N2 overlay, dO2 levels increased over time due to surface transfer
`from air in the headspace, which was also facilitated by the higher
`agitation rate. Based on these results, 50 rpm was selected as the
`agitation rate for future studies and a N2 overlay was employed for
`most sparge experiments, unless otherwise specified, since it
`represented a worst case environment for antibody reduction. As an
`exception, no N2 overlay was used for non-sparged hold cases where
`dO2 trends were being observed. Surface transfer is expected to be
`less significant in a manufacturing-scale tank due to a smaller
`surface area-to-volume ratio.
`Gas transfer in bioreactors occurs through two interfaces, one
`between the liquid and sparged bubbles and the other between the
`liquid surface and tank headspace. To characterize the small-scale
`sparge model, kLa values were measured at varying agitation and
`sparge rates through both the sparger and headspace. As shown in
`Table I, the sparger kLa was 2.5-fold higher at a sparge rate of
`50 sccm versus 10 sccm. In addition, the lower agitation rate
`decreased the headspace kLa slightly but did not significantly
`impact gas transfer through the sparger. These results further
`confirm the selection of a 50 rpm agitation rate in order to minimize
`the surface transfer yet provide adequate mixing. No difference was
`observed in the headspace kLa with a 50 sccm or 250 sccm overlay,
`so 50 sccm was chosen for future studies. Overall, the headspace kLa
`values were relatively low compared to the sparger kLa values within
`the range of sparge rates discussed in this work. This suggests that
`sparge rates were the main driver in the observed results and that
`headspace transfer played a relatively minor role.
`In order to optimize the sparge vessel conditions to adequately
`maintain a dO2 set-point of 30%, a study was performed to compare
`a 10 or 50 sccm maximum air sparge rate. Lysed HCCF (85% lysis)
`was held in sparge vessels with an agitation rate of 50 rpm and a
`
`

`

`Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 4 of 9 PageID #: 9526
`
`Table I. Sparger and headspace kLa values in the small-scale sparge
`model at varying agitation and sparge rates.
`
`Agitation
`(rpm)
`
`Sparge rate
`(sccm)
`
`Sparger kLa
`(hr1)
`
`Headspace kLa
`(hr1)
`
`50
`
`100
`
`10
`50
`250
`10
`50
`250
`
`0.28
`0.75
`—
`—
`0.68
`—
`
`—
`0.12
`0.13
`—
`0.15
`0.16
`
`50 sccm N2 overlay and dO2 trends were monitored for each
`condition. As shown in Figure 2, a maximum sparge rate of 10 sccm
`provided insufficient gas transfer to maintain the dO2 set-point
`early in the hold, while a maximum sparge rate of 50 sccm provided
`immediate and reliable control at the dO2 set-point. Therefore, a
`maximum sparge rate of 50 sccm, which corresponds to a kLa of
`0.75 hr1, was chosen for future studies.
`
`Profile of Lysed HCCF in the Sparge Model
`
`To characterize the behavior of lysed HCCF, material at several lysis
`levels was held in small-scale sparge vessels with 50 rpm agitation,
`no air sparge, and no N2 overlay. Correlations were observed
`between cell lysis levels, the amount of oxygen consumed, and
`rMAb reduction for several CHO production cell lines. Figure 3A
`shows that an increase in cell lysis levels resulted in an increase in
`oxygen consumption. For the non-lysed (10% lysis) and 20% lysis
`cases, oxygen consumption was minimal and the levels of dO2
`remained relatively high. Conversely, at higher total cell lysis levels
`of 45 and 65%, the oxygen demand was high and resulted in the
`depletion of dO2. These trends suggest that HCCF dO2 levels could
`be used as an indicator for lysis levels and the potential for rMAb
`reduction at manufacturing-scale. However, absolute values from
`the small-scale model cannot be applied to manufacturing-scale
`due to differences in behavior and operations between scales (e.g.,
`
`Figure 2. dO2 trends for HCCF (85% total lysis; 65% mechanical lysis) controlled at
`30% dO2 set-point with two maximum sparge rates in the small-scale sparge vessel.
`
`Figure 3. Results showing the correlation between cell
`lysis levels and (A)
`Dissolved oxygen levels; (B) rMAb reduction. Lysis values listed reflect total lysis levels
`(‘‘non-lysed’’ (10%)þ mechanical lysis). In this study, the CCF was harvested at 90%
`viability, which was confirmed by the LDH assay and represented 10% lysis. Data were
`collected over a two-day hold in the sparge vessels.
`
`surface transfer, overlay pressure, hydrostatic pressure). The
`maximum oxygen consumption rate observed in the small-scale
`model was approximately 60%/h for the same cell line tested in
`Figure 3A, using a perturbation oxygen uptake rate (OUR)
`algorithm at 100% total
`lysis (data not shown). Concurrent
`implementation of other reduction mitigation strategies, such as
`lower temperature or chemical inhibitors, has also been shown to
`impact dO2 levels (data not shown).
`In addition to dO2 levels, cell lysis levels were also found to
`impact the level of rMAb reduction, which is consistent with
`previous findings (Trexler-Schmidt et al., 2010). Different threshold
`lysis levels are required for rMAb reduction to occur in different cell
`lines (data not shown). In Figure 3B, the results after a one-day hold
`show that intact rMAb levels were lower at the higher lysis levels.
`Higher levels of intact rMAb were observed after the two-day hold
`presumably due to a decrease in sample reduction activity following
`the depletion of enzyme pathway reducing agents after an extended
`hold time, which allowed the rMAb to re-oxidize to its lowest energy
`state. Results from previous experiments also support that the
`maximum reduction activity is observed within the first 24 h of
`incubation with active reducing components (data not shown).
`
`Mun et al.: Air Sparging for Prevention of Antibody Reduction
`
`737
`
`Biotechnology and Bioengineering
`
`

`

`Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 5 of 9 PageID #: 9527
`
`While high lysis conditions result in both oxygen depletion (Fig. 3A)
`and rMAb reduction (Fig. 3B), oxygen depletion alone is not
`sufficient to trigger reduction. Material with low reduction activity
`was sparged with N2 to drive down the oxygen levels to 0% and no
`rMAb reduction was observed (data not shown). Therefore, a
`combination of sufficient reduction activity and low dO2 levels are
`required for the reduction event to occur.
`
`Impact of Air Sparging Strategies on rMAb Reduction
`Inhibition
`
`Two potential air sparging strategies were explored: constant sparge
`rates with variable dO2 levels and constant dO2 levels with variable
`sparge rates. In order to determine the minimum level of air
`sparging required to inhibit rMAb reduction, a range of air flow
`rates of 5–50 sccm and a range of dO2 levels of 10–50% were tested
`with lysed HCCF (65–85% lysis) that was shown to be susceptible to
`disulfide bond reduction in the non-sparged control vessel. The dO2
`control was one-sided with air supplied up to a maximum sparge
`rate of 50 sccm to maintain the set-point. All cases had a N2 overlay
`except for the 50 sccm constant sparge case. Figure 4A shows the
`levels of intact rMAb over a two-day hold period for the various
`sparge strategies tested. Slight reduction was observed for the
`5 sccm constant sparge case after a two-day hold time, however, the
`degree of reduction was decreased compared to the non-sparged
`control. All other sparge rates and dO2 set-points were found to be
`sufficient to prevent disulfide bond reduction.
`As shown in Figure 4B, the dO2 levels for the non-sparged control
`case and the 5 sccm sparge case were depleted within one day. This
`indicates that 5 sccm air sparge was unable to provide sufficient
`oxygen supply to maintain the dO2 level above 0% in competition
`with the rate of oxygen consumption by the lysed HCCF. All other
`sparge cases maintained dO2 levels >0% since the sparge rates met
`or exceeded the oxygen consumption rates. Climbing dO2 levels
`were observed for the 50 sccm sparge case as the oxygen delivery
`rate exceeded the consumption rate.
`As shown in Figure 4C, the HCCF pH increased by up to 1.3 units
`over two days as a result of CO2 stripping. The rate of pH increase
`was accelerated at the higher air sparge rates or higher dO2 set-
`points due to increased CO2 mass transfer. Lower rates of CO2
`stripping are expected in a manufacturing-scale HCCF tank because
`the lower liquid surface-to-volume ratio reduces CO2 mass transfer
`(Matsunaga et al., 2009).
`When choosing an appropriate HCCF air sparging strategy, it is
`desirable to minimize the amount of air sparge delivered to decrease
`CO2 stripping and the subsequent increase in pH and potential
`impact on product quality. The use of a minimum dO2 set-point
`provides feedback control and scales the air output appropriately to
`meet demand. This ensures that adequate air is supplied to
`maintain dO2 levels >0% and prevent antibody reduction, while
`also preventing the addition of excess air sparge. Therefore, a sparge
`strategy of dO2 control was selected as the preferred antibody
`reduction mitigation strategy for further evaluation. A 30%
`minimum dO2 set-point was chosen because it is commonly used in
`mammalian cell culture production bioreactors and has been shown
`to be robust and achievable, leaving a sufficient safety factor on the
`lower end, while not over-sparging.
`
`738
`
`Biotechnology and Bioengineering, Vol. 112, No. 4, April, 2015
`
`Figure 4. HCCF with 65–85% total lysis (40–55% mechanical lysis) was tested with
`multiple air sparge strategies. A N2 overlay was used in all cases except for the
`50 sccm constant sparge case. Results show trends of (A) rMAb reduction, (B)
`Dissolved oxygen, (C) pH change.
`
`Air Sparge Requirement Per Lysed Cell
`
`Figure 5A,B shows an assessment of the amount of air that is
`required to maintain a 30% dO2 set-point for a single cell line at
`three lysis levels. As seen in Figure 3A, the amount of oxygen
`consumed is dependent upon the level of cell
`lysis. In this
`experiment, lysed HCCF was held in sparge vessels with or without
`a N2 overlay to assess extreme conditions with respect to additional
`
`

`

`Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 6 of 9 PageID #: 9528
`
`oxygen transfer from the liquid surface. These conditions bracket
`the expected surface oxygen transfer rate of a manufacturing-scale
`HCCF tank. As predicted, larger volumes of air were required to
`maintain the 30% dO2 set-point for cases with higher levels of cell
`lysis (Fig. 5A). In the presence of a N2 overlay, additional air sparge
`was required to maintain the dO2 set-point. Most of the air sparge
`was required during the first 24 h of the hold time, corresponding to
`the period of maximum reduction activity.
`The air sparge requirement through a 24-hour hold is plotted in
`Figure 5B versus the number of mechanically lysed viable cells. For
`this cell line, the sparge requirement per lysed cell in the small-scale
`model is 3.3 109 L air/lysed cell or 6.9 1010 L O2/lysed cell.
`This value could be used to determine oxygen demand for a
`particular lysis level or gauge relative reduction activity between cell
`lines or culture conditions. Additionally, since a linear correlation is
`observed between required air sparge and the number of lysed cells,
`these data provide confirmation that
`the oxygen-consuming
`
`compounds in the HCCF are being released from the cells upon
`lysis. An alternative approach to defining a dissolved oxygen control
`strategy at manufacturing-scale would be to measure the oxygen
`uptake rate of the cell lysate in order to estimate the required mass
`transfer coefficient in a HCCF vessel.
`
`Air Sparging Effectiveness for Multiple Cell Lines
`
`Since air sparging was found to be a robust and effective method in
`preventing rMAb reduction for one product,
`three additional
`products produced in CHO cell lines were tested in the small-scale
`model and the results are summarized in Figure 6. For all four
`products, air sparging to maintain a minimum 30% dO2 level was
`able to fully prevent reduction and maintain >90% intact rMAb.
`These results show that air sparging can be used as a mitigation
`strategy to prevent rMAb reduction for multiple cell lines with
`varying levels of reduction activity.
`
`Air Sparging Impact on Product Quality
`
`In the manufacture of rMAbs, appropriate process controls are
`important to ensure consistent product quality. Protein product
`quality can be sensitive to variations in cell culture process
`parameters (e.g., temperature, pH, or dO2) and changes could result
`in a shift in product attributes such as glycan distribution, aggregate
`formation, or charge variant profile (Andersen and Goochee, 1994;
`Cromwell et al., 2006; Yoon et al., 2004). Additionally, product
`quality can be impacted by cell-free hold conditions during recovery
`operations or in the final formulation buffer (Cromwell et al., 2006;
`Peters and Trout, 2006; Wang, 1999; Wakankar and Borchardt,
`2006). Implementation of air sparging during the HCCF hold step
`has the potential to impact product quality. Therefore, as with any
`
`Figure 5.
`Totalized volume of air sparge required to maintain a 30% dO2 set-point
`for varying lysis levels in the sparge model with and without a N2 overlay. Lysis values
`listed reflect total lysis levels (‘‘non-lysed’’ (10%)þ mechanical lysis). (A) Plotted with
`time on the x-axis; (B) Totalized air sparge over 24 h on the y-axis and number of
`mechanically lysed cells on the x-axis. The slope of each line represents the volume of
`air sparge required over 24 h per mechanically lysed cell to maintain a 30% dO2 set-
`point.
`
`Figure 6. Results showing the effectiveness of air sparging on preventing
`reduction with four different rMAb products. The dashed bars indicate the no sparge
`condition and the solid bars indicate the sparge condition (30% dO2 set-point with up to
`a maximum 50 sccm sparge rate). Products were tested at a total lysis level conducive
`to reduction (65–85% total lysis; 55–65% mechanical lysis). The HCCF was sampled
`from the sparge vessels and purified over Protein A after 0, 1, and 2 days.
`
`Mun et al.: Air Sparging for Prevention of Antibody Reduction
`
`739
`
`Biotechnology and Bioengineering
`
`

`

`Case 1:18-cv-01363-CFC Document 79-8 Filed 03/22/19 Page 7 of 9 PageID #: 9529
`
`other change to a process, the appropriate product quality analyses
`should be performed to ensure minimal impact.
`Sparged material purified by Protein A was evaluated using SEC-
`HPLC, IEC-HPLC, CE-glycan, and peptide map to evaluate any
`changes to aggregate levels, charge variant distribution, glycan
`distribution, and oxidation, respectively. Based on these analyses,
`air sparging was found to have no significant impact with respect to
`aggregate, glycan, or oxidation profiles (data not shown). However,
`a decrease in the levels of main peak by IEC-HPLC was observed
`with a concurrent
`increase in the levels of acidic variants.
`Experiments were performed to identify the cause of these acidic
`variants by specifically evaluating the effects of sparging and cell
`lysis. Figure 7 displays the effect of 0–50 sccm air sparging on main
`peak levels for HCCF material with a low lysis percentage of 20%
`total
`lysis (10% mechanical
`lysis), which is expected to be
`representative of the lysis levels of manufacturing-generated HCCF.
`Lower main peak was observed with increasing sparge rate. Overall,
`the non-sparged control material had a drop of 1% main peak per
`day while the sparged cases showed an additional 0.5–1.5%
`decrease per day. Previous studies observed a rate of ~2% decrease
`per day which was not considered significant (Trexler-Schmidt
`et al., 2010).
`Next, the effect of cell lysis on the charged variant profile was
`examined. In this experiment, HCCF at different
`lysis levels,
`including a non-lysed control, was sparged at a constant rate to
`ensure that the product in each case had equivalent air exposure. A
`high sparge rate of 50 sccm was selected to assess worst case. The
`results shown in Figure 8 demonstrate that cell lysis contributes to
`the decrease in main peak with as much as a 2% additional decrease
`per day over the non-lysed control for the 100% lysis case. Taken
`together, the results from Figures 7 and 8 indicate that the highest
`levels of acidic variant increase (main peak decrease) would be
`expected for material with both high lysis and high sparge rates.
`
`Figure 7. Non-lysed þ 10% mechanical lysis (20% total lysis) material was tested
`at different levels of constant air sparge (no N2 overlay) to assess the impact of air
`sparging on IEC-HPLC main peak. The HCCF was sampled from the sparge vessels and
`purified using Protein A after 1 and 2 days and submitted for IEC-HPLC analysis. The
`data were compared to non-sparged hold conditions.
`
`740
`
`Biotechnology and Bioengineering, Vol. 112, No. 4, April, 2015
`
`Figure 8. Material at different lysis percentages was sparged at a constant
`sparge rate of 50 sccm (no N2 overlay) to assess the impact of cell lysis on IEC-HPLC
`main peak. Lysis values listed reflect total lysis levels (‘‘non-lysed’’ (10%) þ mechanical
`lysis). The HCCF was sampled from the sparge vessels and purified over Protein A after
`1 and 2 days and submitted for IEC-HPLC analysis. The data were compared to a non-
`lysed control.
`
`Additional studies to help understand the source of the acidic
`variant formation are ongoing. One factor that has been explored is
`the possibility that the pH increase during air sparging, due to CO2
`stripping from the HCCF in the small-scale sparge vessel, leads to
`accelerated deamidation and therefore an increase in acidic variants
`(Patel and Borchardt, 1990; Peters and Trout, 2006).
`
`Discussion
`
`Air sparging has been shown to be a robust and universal mitigation
`strategy to prevent rMAb reduction. While the complete mechanism
`of rMAb reduction prevention has not yet been fully elucidated, the
`consumption of oxygen by cellular metabolic pathways results in the
`exhaustion of nutrient and energy supplies. For example, oxygen
`may convert NADPH, the proposed primary fuel for the reducti

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket